Gut dysbacteriosis and intestinal disease: mechanism and treatment

X. Meng, G. Zhang, H. Cao, D. Yu*, X. Fang, W.M. de Vos, H. Wu

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The gut microbiome functions like an endocrine organ, generating bioactive metabolites, enzymes or small molecules that can impact host physiology. Gut dysbacteriosis is associated with many intestinal diseases including (but not limited to) inflammatory bowel disease, primary sclerosing cholangitis-IBD, irritable bowel syndrome, chronic constipation, osmotic diarrhoea and colorectal cancer. The potential pathogenic mechanism of gut dysbacteriosis associated with intestinal diseases includes the alteration of composition of gut microbiota as well as the gut microbiota–derived signalling molecules. The many correlations between the latter and the susceptibility for intestinal diseases has placed a spotlight on the gut microbiome as a potential novel target for therapeutics. Currently, faecal microbial transplantation, dietary interventions, use of probiotics, prebiotics and drugs are the major therapeutic tools utilized to impact dysbacteriosis and associated intestinal diseases. In this review, we systematically summarized the role of intestinal microbiome in the occurrence and development of intestinal diseases. The potential mechanism of the complex interplay between gut dysbacteriosis and intestinal diseases, and the treatment methods are also highlighted.

Original languageEnglish
JournalJournal of Applied Microbiology
DOIs
Publication statusE-pub ahead of print - 10 Apr 2020

Keywords

  • gut microbiome
  • immune response
  • intestinal diseases
  • prebiotics
  • probiotics

Fingerprint Dive into the research topics of 'Gut dysbacteriosis and intestinal disease: mechanism and treatment'. Together they form a unique fingerprint.

  • Cite this